What vacancy rate exists in major life sciences markets?

Life sciences markets are experiencing approximately 30% vacancy in major markets, a dramatic shift from the post-COVID period when demand for lab space was strong.

What median coupon rate applies to commercial real estate refinancings year-to-date in 2026?

The median coupon for commercial real estate refinancings year-to-date in 2026 is approximately 6.44%. This creates significant refinancing pressure for properties with older debt at lower rates.

What is the ratio of refinance activity to new sales origination in the current commercial real estate market?

As of the discussion, refinance transactions are occurring at approximately seven and a half times the volume of new origination on sales transactions. This reflects capital preservation and distressed refinancing activity.

🎧 Listen to the episode on Listenly

What are the credit metrics and lease roll characteristics of Genesis Towers?

23 September 2026 The TreppWire Podcast: A Commercial Real Estate Show · Stephen Bushbaum

Genesis Towers demonstrates strong credit fundamentals with a 3.11x debt service coverage ratio and a 44.2% loan-to-value, but the property faces significant lease rollover pressure: approximately one-third of the building's space expires within the next two years, with 21% rolling in the immediate 12-month window. The fixed-rate loan matures in 2030 at just over 2.6% coupon.

Strong Credit Against Mounting Occupancy Risk

The Genesis Towers financial position initially appears resilient. The 3.11x debt service coverage ratio exceeds typical lender thresholds, and the 44.2% LTV provides meaningful equity cushion. However, these metrics mask an underlying structural challenge that is becoming increasingly difficult to navigate in today's life sciences market.

Current occupancy stands at 73%, already below the pre-pandemic baseline many investors expect in this property class. More critically, as Stephen Bushbaum details in the episode, the lease roll schedule creates a refinancing window fraught with uncertainty: 21% of tenants renew within 12 months, and another 9% between months 13–24, effectively putting one-third of revenues at risk before the loan matures in 2030.

The Lease Roll Paradox: Low Rates, High Uncertainty

The property's 2.6% coupon is an accident of timing—a legacy from an earlier refinancing before the 2024–2026 rate environment reset. This below-market rate provides breathing room on debt service. Yet that advantage evaporates if significant lease space fails to renew, compressing net operating income and forcing either aggressive re-tenanting, rent concessions, or eventual recapitalization at far higher rates.

Life sciences markets across major hubs—from the Bay Area to San Diego—are grappling with approximately 30% vacancy in major markets, a structural headwind unlike the post-COVID era when demand for lab space seemed infinite. Genesis Towers' 73% occupancy is not dramatically out of line with sector trends, but the concentration of lease expirations means the property has little room for error.

"Maturity is the great synchronization event that forces all of these clocks to come into sync."

Stephen Bushbaum — Head of Applied Research and Analytics, Trep. Bushbaum leads Trep's research division, where he develops analytical frameworks to understand how commercial real estate market dynamics—property performance, capital availability, and credit conditions—interact during periods of stress. His three-clock model has become a core lens for analyzing how different market signals align or diverge during maturity and refinancing events.

For Genesis Towers, that synchronization is already underway. The property's solid credit metrics today rest on occupancy and rental rates that may not hold through 2030. If tenants fail to renew or demand significant rent reductions, the DSCR compresses rapidly. Meanwhile, with current commercial real estate refinancing coupon rates hovering near 6.44% year-to-date 2026, any refinancing would come at a sharp multiple of the current 2.6% fixed rate, compounding the challenge.